GenprexOffering
Completed S-1 IPO NASDAQ: GNPX Lung Cancer Clinical Stage Gene Therapy
Completed S-1 IPO NASDAQ: GNPX Lung Cancer Clinical Stage Gene Therapy
and investor. In his twenties, he founded and developed a company with $40 million ...
The question is what is the cost to take my company public using Regulation A+ on Manhattan Street Capital? These are the costs. The first cost is marketing so probably the minimum you could get away with for an offering ...
of view. What I am most excited about is the potential for quality of life ...
is interesting from a financial point of view. What I am most excited about ...
fertilization, pool, and other outdoor automated systems. What is Skydrop™ Skydrop™ ...